NCT05144984 A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT05119179 Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes Status RECRUITING Phase PHASE4
NCT05035082 A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE) Status COMPLETED Phase PHASE4
NCT04979130 Comparing Semaglutide Versus Placebo on Intestinal Barrier Function in Type 2 Diabetes Mellitus (SIB) Status COMPLETED Phase PHASE4
NCT04940078 A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Combined Versus Separate Injections in People With Overweight or Obesity Status COMPLETED Phase PHASE1
NCT04916470 Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT04889183 SeMaglutide and Albuminuria Reduction Trial in Obese Individuals Without Diabetes Status COMPLETED Phase PHASE3
NCT04878406 A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Japanese Men Status COMPLETED Phase PHASE1
NCT04865770 A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trial) Status COMPLETED Phase PHASE3
NCT04822181 Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04788511 Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and Obesity Status COMPLETED Phase PHASE3
NCT04777409 A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus) Status COMPLETED Phase PHASE3
NCT04615871 Semaglutide to Reduce Myocardial Injury in PATIents With COVID-19 Status UNKNOWN Phase PHASE2
NCT04560998 A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT04538352 Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With T2D Status COMPLETED Phase PHASE4
NCT04515849 A Study of Cotadutide in Participants Who Have Chronic Kidney Disease With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT04469855 Post-Marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ozempic® Status COMPLETED Phase N/A
NCT04466345 Semaglutide for the Treatment of Cognitive Dysfunction in Major Depressive Disorder Status COMPLETED Phase PHASE2